ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1138

Public Health Impact of Physical Inactivity in the Knee OA Population in the US

Elena Losina1, Genevieve S. Silva2, Karen C. Smith2, Jamie E. Collins3, David J. Hunter4, Swastina Shrestha2, Stephen P. Messier5, Edward H. Yelin6, Lisa Gale Suter7, A. David Paltiel8 and Jeffrey N. Katz9, 1Orthopedics, Brigham and Women's Hospital, BU School of Public Health and Harvard Medical School, Boston, MA, 2Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 3Department of Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 4Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 5Department of Health and Exerc, Wake Forest University, Winston-Salem, NC, 6Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 7Rheumatology, Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT, 8Yale University, New Haven, CT, 9Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Knee, Osteoarthritis, Physical activity and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The benefits of physical activity (PA) in persons with OA are well-documented: PA reduces OA pain, improves mental health, and reduces the risk of cardiovascular disease (CVD), diabetes mellitus (DM), and some cancers. Despite this, the majority of knee OA patients are physically inactive. The public health impact of low uptake of PA in this population has not been evaluated.

Methods: We used data from the Osteoarthritis Initiative and Centers for Disease Control to estimate the proportion of the US knee OA population that is inactive, insufficiently active, and active, defined as 0-10, 10-149, and 150+ minutes of moderate-to-vigorous PA per week. Using the Osteoarthritis Policy Model (OAPol), a widely published and validated microsimulation of knee OA, we estimated survival and quality-adjusted survival losses among cohorts of individuals with knee OA and different levels of PA. We calculated the per person quality-adjusted years of life (QALYs) lost among those who are inactive or insufficiently active compared to those who are active. We estimated the negative public health impact by multiplying the per-person QALYs lost due to physical inactivity or insufficient activity by the number of persons with knee OA in each of those activity groups. We also calculated the positive public health impact of increasing PA levels among knee OA patients (assuming interventions that could lead 5% or 10% of the population at lower PA levels to increase their activity) by calculating QALYs saved and cases of CVD, DM, and cancer prevented due to such interventions. OAPol data inputs were derived from national and multicenter cohorts and included: 1) background mortality rates; 2) prevalence of and mortality attributable to CVD, DM, and cancers; 3) reduction in quality of life due to physical inactivity and major comorbidities; 4) increased risk of comorbidities due to physical inactivity.

Results: Currently, of 11.7 million persons in the US with knee OA, 47% are inactive and 41% are insufficiently active, resulting in 6.7 million QALYs lost over their remaining lifespan. Table 1 presents the positive public health impact of PA interventions. If an intervention could simultaneously lead 10% of inactive persons to become insufficiently active and 5% of insufficiently active persons to become active over their remaining life spans, 316,181 QALYs would be saved (191,718+124,463, Table 1, QALYs row, shaded cells). This would also prevent 80,379 (63,817+16,562, Table 1, CVD row, shaded cells) cases of CVD and 85,425 (71,768+13,657, Table 1, DM row, shaded cells) cases of DM.

Conclusion: These results suggest that even modestly effective programs focused on increasing PA among knee OA patients could have a tremendous public health impact. Our projections of improvements in morbidity and mortality could be useful in setting realistic goals for activity promotion among knee OA patients.


Disclosure: E. Losina, Samumed, 5,JBJS, 5; G. S. Silva, None; K. C. Smith, None; J. E. Collins, None; D. J. Hunter, None; S. Shrestha, None; S. P. Messier, None; E. H. Yelin, None; L. G. Suter, None; A. D. Paltiel, None; J. N. Katz, None.

To cite this abstract in AMA style:

Losina E, Silva GS, Smith KC, Collins JE, Hunter DJ, Shrestha S, Messier SP, Yelin EH, Suter LG, Paltiel AD, Katz JN. Public Health Impact of Physical Inactivity in the Knee OA Population in the US [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/public-health-impact-of-physical-inactivity-in-the-knee-oa-population-in-the-us/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/public-health-impact-of-physical-inactivity-in-the-knee-oa-population-in-the-us/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology